Skip to main content

Table 1 Clinical features of two half-sisters with Imerslund-Gräsbeck syndrome

From: Novel compound heterozygous mutations in AMN cause Imerslund-Gräsbeck syndrome in two half-sisters: a case report

ID

Age at diagnosis [years]

B12 deficient

B12 level on treatment [ng/L]

Serum Creatinine [μmol/L]

Urinary protein/creatinine ratio [mg/mmol]

Urinary protein/creatinine ratio [mg/mmol] during pregnancy

Total Vitamin D [nmol/L]

24 h urine protein [g/24 h]

Neurological symptoms

III:1

2

Yes

405

64

50–90

56–84

73

0.6–0.7

No

III:2

3

Yes

743

62

66–71

64–90

76

0.65

No